NCT06872229 The Impact of Sensory Integration on Attention in Autism
| NCT ID | NCT06872229 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto per la Ricerca e l'Innovazione Biomedica |
| Condition | Autism |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2026-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-03-01 with a primary completion date of 2026-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to examine how the mode of presentation of visual and auditory stimuli-separate or simultaneous-affects accuracy and reaction time in visual-auditory association in participants with Autism Spectrum Condition (ASC) compared to neurotypical individuals. The study aims to evaluate whether sensory overlap (simultaneous stimuli) increases cognitive load and decreases performance, while stimulus separation (separate presentation of visual and auditory stimuli) may facilitate processing and improve performance, especially in participants with ASC. Participants will be divided into two main groups: the first consisting of individuals with ASD and the second of neurotypical individuals. Each group will be exposed to two modes of stimulus presentation: simultaneous mode, in which visual and auditory stimuli are presented at the same time, and separate mode, in which visual and auditory stimuli are presented separately with a time interval between each. Participants will be required to complete visual-auditory association tasks. In addition to assessment of reaction time and accuracy, psychophysiological parameters will be recorded to measure cognitive load and physiological reaction to stimuli. The main hypotheses are that the simultaneous presentation of visual and auditory stimuli will increase cognitive load and reduce accuracy and reaction time in individuals with ASC, while the separate mode will improve performance, especially in the group with ASC. This study could provide important insights into how stimulus presentation mode affects learning and performance in participants with ASC, suggesting that stimulus separation could be a useful strategy for optimizing sensory processing and improving learning in educational and therapeutic settings.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of Autism * QI ≥ 80 Exclusion Criteria: * significant hearing or visual impairments * presence of other medical disorders * history of psychiatric diagnosis
Contact & Investigator
Flavia Marino
PRINCIPAL INVESTIGATOR
Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)
Frequently Asked Questions
Who can join the NCT06872229 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 12 Years, studying Autism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06872229 currently recruiting?
Yes, NCT06872229 is actively recruiting participants. Contact the research team at ileana.scarcella@irib.cnr.it for enrollment information.
Where is the NCT06872229 trial being conducted?
This trial is being conducted at Messina, Italy.
Who is sponsoring the NCT06872229 clinical trial?
NCT06872229 is sponsored by Istituto per la Ricerca e l'Innovazione Biomedica. The principal investigator is Flavia Marino at Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR). The trial plans to enroll 100 participants.